The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth <i>In Vivo</i> and Potentiates RadiotherapyKatrine Ingelshed(Karolinska Institutet), Saikiran K. Sedimbi(Karolinska Institutet)Cancer Research CommunicationsAugust 19, 202210.1158/2767-9764.crc-22-0053Cited by 14SaveCiteExport RISWatch citationsRelated PapersMDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors|iScience|2024|14